Recent Articles from GlobeNewswire

NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) --

NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) --

NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) --

NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) --

NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) --

NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) --

NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) --

THE WOODLANDS, Texas, Oct. 05, 2026 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (NASDAQ: LGIH) today announced it closed 386 homes in September 2026, including 8 currently or previously leased single-family rental homes. This represents a 9.0% increase compared to 354 homes closed in September 2025. Additionally, the Company closed 1,222 homes during the third quarter of 2026, including 33 currently or previously leased single-family rental homes. This represents a 10.4% increase compared to 1,107 homes closed in the third quarter of 2025.

Kansas City, Mo., Oct. 05, 2026 (GLOBE NEWSWIRE) -- CPESN® USA, a clinically integrated, nationwide organization of pharmacy networks advancing community-based pharmacy practice, today announced that Sanjay Patel, RPh, has been named the recipient of the 2026 CPESN Luminary of the Year Award, sponsored by Prasco. 

IRVINE, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Skyworks Solutions, Inc. (Nasdaq: SWKS) (“Skyworks”), a leading developer, manufacturer and provider of analog and mixed-signal semiconductors and solutions for numerous applications, today announced the expiration and final results of its previously announced offers to holders of Qorvo Notes (as defined herein) to exchange (the “Exchange Offers”) any and all outstanding 4.375% Senior Notes due 2029 (the “2029 Qorvo Notes”) and any and all outstanding 3.375% Senior Notes due 2031 (the “2031 Qorvo Notes” and, together with the 2029 Qorvo Notes, the “Qorvo Notes”) issued by Qorvo, Inc. (“Qorvo”) as set forth in the table below for (1) with respect to the 2029 Qorvo Notes, up to $850,000,000 aggregate principal amount of new 4.375% Senior Notes due 2029 (the “New 2029 Skyworks Notes”) issued by Skyworks and (2) with respect to the 2031 Qorvo Notes, up to $700,000,000 aggregate principal amount of new 3.375% Senior Notes due 2031 (the “New 2031 Skyworks Notes”) issued by Skyworks.

Reflects strong demand for in-person learning and connection across the meetings and event industry

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Aardvark (AARD) To Contact Him Directly To Discuss Their Options

Bragar Eagel & Squire, P.C. Litigation Partners Brandon Walker and Melissa Fortunato Encourage Investors Who Suffered Losses In UWM To Contact Them Directly To Discuss Their Options

BOSTON, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, on October 1, 2026, the Compensation Committee of the Board of Directors granted stock options to purchase an aggregate of 59,250 shares of Vor Bio’s common stock and restricted stock units (“RSUs”) representing the right to receive an aggregate of 12,550 shares of Vor Bio’s common stock to 9 newly hired employees. The foregoing stock options and RSUs were granted as material inducements to employment with Vor Bio in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Vor Biopharma Inc. 2023 Inducement Plan (the “Inducement Plan”).        

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Coastal (CCB) To Contact Him Directly To Discuss Their Options

If you purchased or acquired Simply Good Foods common stock between October 24, 2024 and April 8, 2026 and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at investigations@bespc.com or by telephone at (212) 355-4648.

Bragar Eagel & Squire, P.C. Litigation Partners Brandon Walker and Melissa Fortunato Encourage Investors Who Suffered Losses In HDFC Bank (HDB) To Contact Them Directly To Discuss Their Options

NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) --

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Enova (ENVA) To Contact Him Directly To Discuss Their Options

VANCOUVER, British Columbia, Oct. 05, 2026 (GLOBE NEWSWIRE) -- NOVAGOLD RESOURCES INC. (“NOVAGOLD” or the “Company”) (NYSE American, TSX: NG) today announced that it has filed and commenced mailing its management information circular and definitive proxy statement (the “Circular and Proxy Statement”) and related proxy materials (collectively, the “Meeting Materials”) for the special meeting of shareholders to be held on November 3, 2026 (the “Meeting”). At the Meeting, shareholders of record at the close of business on September 23, 2026 (the “Record Date”) will be asked to consider and, if deemed advisable, approve, with or without variation, (i) a special resolution (the “Arrangement Resolution”) approving a Plan of Arrangement (the “Arrangement”), relating to the transactions announced on July 22, 2026, pursuant to which, subject to the satisfaction of certain closing conditions, upon the consummation thereof, NovaGold Corporation, a newly incorporated Delaware company (“New NOVAGOLD”), would become the ultimate parent of NOVAGOLD and its subsidiaries and would acquire the 40% interest in Donlin Gold LLC (“Donlin Gold”) held by Paulson Advisers LLC and certain of its affiliates (collectively, “Paulson”) through Donlin Gold Holdings LLC (“Donlin Gold Holdings”)1, increasing NOVAGOLD’s ownership from 60% to 100% in its Tier One2 gold development project in Alaska (the “Transactions”), and (ii) the other resolutions summarized below, each of which is described in greater detail in the Circular and Proxy Statement.

CALGARY, Alberta, Oct. 05, 2026 (GLOBE NEWSWIRE) --

MILWAUKEE, Wis., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Fiserv, Inc. (NASDAQ: FISV), a leading global provider of payments and financial services technology solutions, will announce its third quarter financial results before the market opens on Tuesday, November 3, 2026. The company will discuss its results in a live webcast at 7 a.m. CT (8 a.m. ET) on November 3, 2026. The webcast, along with supplemental financial information, can be accessed on the investor relations section of the Fiserv website at investors.fiserv.com. A replay will be available approximately one hour after the conclusion of the live webcast.

Analyst Conference Call – 8:00 a.m. Pacific, Friday, November 6, 2026

Jackery and Pebble deliver outdoor mobile energy independence with a new self-powered package for the 2027 Pebble Flow

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Anavex (AVXL) To Contact Him Directly To Discuss Their Options

WISeQey Begins Trading on Nasdaq and SIX as WQEY

ENGLEWOOD, Colo., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announced that it will release third quarter 2026 earnings results on Tuesday, November 3, 2026 after market close. Following the release of its results, Patrick S. Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer, will host an interactive conference call on Wednesday, November 4, 2026, at 9:00 a.m. ET.

DUBAI, United Arab Emirates, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Micropolis AI Robotics (NYSE American: MCRP) (the “Company”) today announced that it received a letter from NYSE Regulation dated September 29, 2026, notifying the Company that it is not in compliance with the stockholders’ equity requirement in Section 1003(a)(ii) of the NYSE American Company Guide (the “Company Guide”).

ST. JOHN'S, Newfoundland and Labrador, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Fortis Inc. ("Fortis" or the "Corporation") (TSX/NYSE: FTS) will release its third quarter 2026 financial results and new five-year capital outlook for the period 2027-2031 on Tuesday, November 3, 2026. A teleconference and webcast will be held the same day at 8:30 a.m. (Eastern). David Hutchens, President and Chief Executive Officer and Jocelyn Perry, Executive Vice President and Chief Financial Officer will discuss the Corporation's third quarter financial results and five-year capital outlook.

Atlanta, GA, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Piedmont Realty Trust (NYSE: PDM) announced today that the Company will release its third quarter financial results on Monday, October 26, 2026, after the close of trading on the New York Stock Exchange. A conference call is scheduled for Tuesday, October 27, 2026, at 9:00 a.m. ET and will be broadcast live in listen-only mode on the company’s investor relations website. During the conference call, the Company’s management team will review third quarter performance, discuss recent events, and conduct a question-and-answer period.

JACKSONVILLE, Fla., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Proficient Auto Logistics, Inc. (NASDAQ: PAL) (the “Company”) today announced that it will host an investor conference call at 5:00 p.m. EST on Thursday, November 12, 2026, to discuss its operating and financial results for the three months ended September 30, 2026. A press release disclosing those results will be issued at approximately 4:00 p.m. EST on that day. Investors are invited to join the conference call by registering through this link: https://register-conf.media-server.com/register/BIc2da8649a37c46c49f861e957053685f, once registered, you will receive a dial-in and a unique pin to join the conference. You may also join the listen-only Webcast via https://edge.media-server.com/mmc/p/fjiisait.

SAN CARLOS, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company, today announced that it has commenced underwritten public offerings of $500 million of its common stock and pre-funded warrants and $500 million aggregate principal amount of convertible senior notes due 2032 (the “notes”) in separate public offerings registered under the Securities Act of 1933, as amended. All shares of common stock, pre-funded warrants and notes to be sold in the offerings will be offered by Vaxcyte. Vaxcyte intends to grant the underwriters a 30-day option to purchase up to an additional $75 million of shares of its common stock, and expects to grant the underwriters a 30-day option to purchase up to an additional $75 million aggregate principal amount of notes solely to cover over-allotments. The completion of the common stock and pre-funded warrant offering will not be contingent on the completion of the note offering, and the completion of the note offering will not be contingent on the completion of the common stock and pre-funded warrant offering. The offerings are subject to market and other conditions, and there can be no assurance as to whether or when either offering may be completed, or as to the actual size or terms of either offering.

PERRYSBURG, Ohio, Oct. 05, 2026 (GLOBE NEWSWIRE) -- O-I Glass, Inc. (NYSE: OI) has scheduled its third quarter 2026 conference call and webcast for Wednesday, October 28, 2026, at 8 a.m. EDT. The Company’s news release for the third quarter 2026 earnings will be issued after the market closes on Tuesday, October 27.

LITTLE ROCK, Ark., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Uniti Group Inc. (“Uniti”) (Nasdaq: UNIT) announced today that it will report its third quarter 2026 financial results prior to the opening of trading on the Nasdaq Stock Exchange on November 9, 2026. A conference call to discuss those earnings will be held the same day at 8:30 AM Eastern Time.

INDIANAPOLIS, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Kite Realty Group (NYSE: KRG) announced today that it will release financial results for the quarter ended September 30, 2026, before the market opens on Friday, October 30, 2026. KRG will conduct a conference call to discuss its financial results on Friday, October 30, 2026 at 11:00 a.m. Eastern Time.

Holders of Debentures Issued in April 2026 Agree to Extend Maturity through February 2027

TULSA, Okla., Oct. 05, 2026 (GLOBE NEWSWIRE) -- ONEOK, Inc. (NYSE: OKE) will release third-quarter 2026 earnings after the market closes on Oct. 27, 2026. Members of ONEOK’s management team will participate in a conference call the following day.

BOSTON, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Merlin, Inc. (Nasdaq: MRLN), an aerospace and defense technology company building the operating system of record for autonomous flight, today announced its management is scheduled to participate in three investor conferences in the fourth quarter of 2026.        

IRVINE, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced an oral presentation will be featured at the upcoming American Society of Nephrology Kidney Week 2026 Annual Meeting taking place in Denver, CO, from October 21-25, 2026. The oral presentation will highlight patient-reported outcomes from the Phase 2 BESTOW trial evaluating tegoprubart for the prevention of rejection in kidney transplantation.

KING OF PRUSSIA, Pa., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Universal Health Services, Inc. (NYSE: UHS) announced today that it will report results for its third quarter ended September 30, 2026, after the market closes on Monday, October 26, 2026. There will be a conference call for investors and analysts on Tuesday, October 27, 2026, at 9:30 a.m. Eastern Time.

Net Asset Value Expected to be $12.25 to $12.75 Per Share

Multi-year renewal extends Adeia’s long-standing relationship with the nation’s leading video provider

MONTREAL, Oct. 05, 2026 (GLOBE NEWSWIRE) -- NanoXplore Inc. (“NanoXplore” or the “Company”) (TSX: GRA and OTCQX: NNXPF) today announced that its wholly owned subsidiary, VoltaXplore Inc. (“VoltaXplore”), has created an Advisory Board to provide strategic guidance as it advances its battery manufacturing strategy, and has appointed Mr. Jonathan Blanshay, founder and Chief Executive Officer of Galvion Inc., as its first member. Galvion Inc. is a global defence company that designs, develops and delivers advanced head systems, intelligent power and data management solutions, and integrated soldier systems. The company has a long history of defence innovation, developing and fielding technologies that address evolving operational requirements.

Strengthens leadership team with appointments of John Brottem as general counsel and Amelia Merrill as chief people officer

CHICAGO, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Sprout Social, Inc. (“Sprout Social”, the “Company”, “Sprout”) (NASDAQ: SPT), a leading AI-powered Social Intelligence Platform, today announced that it will report its financial results for the third quarter ending September 30, 2026 after market close on Tuesday, November 3, 2026.

SOUTH SAN FRANCISCO, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced five abstracts have been accepted for presentation at the American Association for the Study of Liver Disease’s (AASLD) The Liver Meeting® 2026, being held November 5 – 9, 2026 in Denver, CO. The abstracts released today can be found on the AASLD website at https://www.aasld.org/the-liver-meeting.

- October 6 YouTube premiere featuring Sway Calloway, Howard “H” White and leading medical and cultural voices anchors community education nationwide

WALTHAM, Mass., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology company committed to developing next-generation therapies that elevate the standard in immunology by delivering more complete disease control, greater durability, and a simpler treatment experience for patients, today announced that it has commenced an underwritten public offering of its common stock. In addition, the Company is expected to grant the underwriters of the offering an option for a period of 30 days to purchase an additional 15% of the shares of common stock offered in the public offering under the same terms and conditions. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

PHILADELPHIA, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a late-stage clinical biotechnology company focused on developing and launching curative targeted cell therapies designed specifically for patients with autoimmune diseases, today announced the grant of inducement equity awards to four newly hired non-executive employees as a material inducement to commencing their employment with the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).

BOCA RATON, FL, Oct. 05, 2026 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company”), the first U.S. public company with a treasury strategy built around accumulating and compounding Solana (SOL), today announced it will host its August & September 2026 Recap & Ask Me Anything (“AMA”) on Tuesday, October 6, 2026, at 12:00 p.m. ET via X Spaces.

Final delivery and training under LAND 159 Tranche 1 supports Australian Army sniper capability

ORIC-259 is a potential first-in-class small molecule mRNA degrader targeting CIP2A, a previously undruggable target

STONY BROOK, N.Y., Oct. 05, 2026 (GLOBE NEWSWIRE) -- iCell Gene Therapeutics ("iCell Gene"), a clinical-stage biopharmaceutical company developing autologous and in vivo CAR T cell therapies for autoimmune diseases and cancer, today announced that Jennifer Chow, CEO will present and meet with investors and potential partners at the following upcoming conference:

RED BANK, N.J., Oct. 05, 2026 (GLOBE NEWSWIRE) -- OceanFirst Financial Corp. (NASDAQ: OCFC) (the “Company”), the holding company for OceanFirst Bank N.A. (the “Bank”), today announced that it will release its third quarter 2026 financial results after the market close on Tuesday, October 27, 2026. Management will host a conference call to discuss the results at 8:00 a.m. Eastern Time on Wednesday, October 28, 2026.

New AI-powered security workforce capabilities, modern firewall innovations, and frictionless secure access help MSPs scale security operations and combat increasingly automated threats

CHICAGO, Oct. 05, 2026 (GLOBE NEWSWIRE) -- What do environmental toxins, the substances circulating in our blood and emerging research into cognitive health have to do with one another?

NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Click Therapeutics, Inc., today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance (marketing authorization) for Motivista, a prescription digital therapeutic (PDT) indicated for the treatment of negative symptoms of schizophrenia, as an adjunct to clinician-managed outpatient care, including antipsychotic therapy in patients 18 years of age and older with clinically stable positive symptoms. Motivista is the first FDA-authorized treatment indicated specifically for the treatment of negative symptoms of schizophrenia in the United States.

Chicago, Oct. 05, 2026 (GLOBE NEWSWIRE) --

NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Alphabet Inc. (“Alphabet” or the “Company”) (NASDAQ: GOOG, GOOGL) between May 19, 2026 and July 16, 2026, inclusive.What To Do Next:

BALA CYNWYD, Pa., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

BOSTON, Oct. 05, 2026 (GLOBE NEWSWIRE) -- The Atlas, Boston's newly opened lifestyle hotel at the gateway of Harvard’s Enterprise Research Campus (ERC), reveals its new series of dynamic Fall programs and events for guests and locals visiting Boston this season. Kicking off the season is the hotel’s official partnership announcement with Head Of The Charles Regatta, the world’s largest three-day rowing event along the Charles River, a new in-room wellness partnership with Boston-based rowing tech pioneers Hydrow, enhanced programming with in-house partners at The COOP, Pearl & Law Hospitality, and Allstonway, and the debut of The Atlas Scholars Club built to create exclusive perks and experiences for the Harvard and Boston’s larger academic community.

MIAMI, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Global beauty brand MONAT continues to push the boundaries of innovation with the launch of two highly anticipated new products during the first two stops of its MONATions World Tour: MONAT GLOSS MODE™, designed to deliver the coveted “glass hair” look, and MONAT MODERN GLOW™ Skin Tint, a skincare-powered complexion enhancer.

Three-year award provides Xacta license maintenance, training and cyber services for Air Force ISR systems

New York, Oct. 05, 2026 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) congratulates Karl Deisseroth, M.D., Ph.D., on receiving the 2026 Nobel Prize in Physiology or Medicine for his pioneering work in optogenetics.

Company Announcement

BEDMINSTER, N.J., Oct. 05, 2026 (GLOBE NEWSWIRE) --

Laura Catalusci joins McKinney Health to lead the new practice and help healthcare brands better understand and act on the lived experience of patients

TORONTO, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Discovery Mining Ltd. (TSX: DSV, OTCQX: DSVSF) (“Discovery” or the “Company”) today confirmed that the Company has received the Cordero Project’s (“Cordero” or the “Project”) environmental impact assessment (“Manifesto de Impacto Ambiental” or “MIA”) permit and the Change of Land Use permit (“Change of Land Use”) from Mexico’s Federal Environmental Department (“SEMARNAT”). Receipt of the MIA and Change of Land Use permits completes the federal environmental permitting process and positions the Company to advance Cordero towards development.

Panel Determines Company Has Regained Compliance With Nasdaq Continued Listing Requirements; Trading on Nasdaq to Be Reinstated on a Date to Be Set by Nasdaq

Hydro provides an update on the natural gas supply situation at the Alunorte alumina refinery.

Leading patient advocacy group calls for modern, easy-to-use epinephrine on all flights to protect passengers with allergies

New itineraries take LGBTQ+ travelers deeper into Sicily, Sri Lanka, Ireland, southern France and beyond, alongside four returning favorites

Exton, PA, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Spherix Global Insights, an independent market intelligence and advisory firm serving the global life sciences industry, today announced the launch of its Obesity Franchise.  The launch brings Spherix’s existing obesity research into a focused franchise, connecting it with the firm’s established gastroenterology/MASH and nephrology/cardiorenal expertise while creating opportunities to expand its publication portfolio and advisory capabilities as treatment decisions increasingly span obesity, cardiometabolic health, and kidney disease.

News Provided by Energy Metal News on behalf of Rua Gold Inc.